Plasminogen activator inhibitor-1 deficiency augments visceral mesothelial organization, intrapleural coagulation, and lung restriction in mice with carbon black/bleomycin-induced pleural injury.
about
Pleural inhibition of the caspase-1/IL-1β pathway diminishes profibrotic lung toxicity of bleomycinThe time course of resolution of adhesions during fibrinolytic therapy in tetracycline-induced pleural injury in rabbits.Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungsThrombin down-regulates tissue factor pathway inhibitor expression in a PI3K/nuclear factor-κB-dependent manner in human pleural mesothelial cells.Mesomesenchymal transition of pleural mesothelial cells is PI3K and NF-κB dependent.NK-CD11c+ Cell Crosstalk in Diabetes Enhances IL-6-Mediated Inflammation during Mycobacterium tuberculosis Infection.Organizing empyema induced in mice by Streptococcus pneumoniae: effects of plasminogen activator inhibitor-1 deficiencyKIF5A transports collagen vesicles of myofibroblasts during pleural fibrosis.Inhibition of Glycogen Synthase Kinase 3β Blocks Mesomesenchymal Transition and Attenuates Streptococcus pneumonia-Mediated Pleural Injury in Mice.Fibrin Turnover and Organization of Pleural Injury: Bench to Bedside.FGF9 prevents pleural fibrosis induced by intrapleural adenovirus injection in mice.Precision-guided, Personalized Intrapleural Fibrinolytic Therapy for Empyema and Complicated Parapneumonic Pleural Effusions: The Case for the Fibrinolytic Potential.Mesothelial to mesenchyme transition as a major developmental and pathological player in trunk organs and their cavities
P2860
Q28395139-F406541A-A3DD-4571-95E0-DD927F8AF8A1Q30374418-D6B3686E-3E5D-4A7F-A3BC-323B364B43A5Q35351530-A38306D1-F85F-4BB9-A045-32BF31B36845Q35816399-C6AB2F4D-AA4D-4C8F-8218-9DA288AB22EFQ35842248-DA3025A9-E41D-4513-A347-FEDE57EF18CAQ36175034-F16EADC5-7F4A-4B65-A014-CB9D9AC78660Q36978644-85657BF0-4AAE-4E7C-B4F6-FEBC62D8DCB4Q40965939-45031250-DF6A-42C5-AE3C-0A9846A88BB1Q47599408-AD96EB24-8CA7-4939-B5CA-C16C41655E5AQ47654038-D9E1DB46-866B-40B0-8EDE-9F50DA2BA3DBQ47684462-9A05BAB0-B47D-4F54-BD1C-467B752752BAQ48617259-2844E575-015E-4AAC-8560-3B77434FA3F2Q57814182-6D7279ED-04D4-47DC-9A52-281C6363745E
P2860
Plasminogen activator inhibitor-1 deficiency augments visceral mesothelial organization, intrapleural coagulation, and lung restriction in mice with carbon black/bleomycin-induced pleural injury.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasminogen activator inhibito ...... omycin-induced pleural injury.
@en
Plasminogen activator inhibito ...... omycin-induced pleural injury.
@nl
type
label
Plasminogen activator inhibito ...... omycin-induced pleural injury.
@en
Plasminogen activator inhibito ...... omycin-induced pleural injury.
@nl
prefLabel
Plasminogen activator inhibito ...... omycin-induced pleural injury.
@en
Plasminogen activator inhibito ...... omycin-induced pleural injury.
@nl
P2093
P2860
P356
P1476
Plasminogen activator inhibito ...... omycin-induced pleural injury.
@en
P2093
Alexia Alvarez
Andrey A Komissarov
Ann Jeffers
Brandon Quaid
Galina Florova
Hema Kothari
Kathleen Koenig
L Vijaya Mohan Rao
Shuzi Owens
Steven Idell
P2860
P304
P356
10.1165/RCMB.2013-0300OC
P577
2014-02-01T00:00:00Z